A20/TNFAIP3 Discriminates Tumor Necrosis Factor (TNF)-Induced NF-κB from JNK Pathway Activation in Hepatocytes

Abstract

In the liver tumor necrosis factor (TNF)-induced signaling critically regulates the immune response of non-parenchymal cells as well as proliferation and apoptosis of hepatocytes via activation of the NF-κB and JNK pathways. Especially, the induction of negative feedback regulators, such as IκBα and A20 is responsible for the dynamic and time-restricted response of these important pathways. However, the precise mechanisms responsible for different TNF-induced phenotypes under physiological stimulation conditions are not completely understood so far. In addition, it is not known if varying TNF concentrations may differentially affect the desensitization properties of both pathways. By using computational modeling, we first showed that TNF-induced activation and downstream signaling is qualitatively comparable between primary mouse hepatocytes and immortalized hepatocellular carcinoma (HCC) cells. In order to define physiologically relevant TNF levels, which allow for an adjustable and dynamic NF-κB/JNK pathway response in parenchymal liver cells, a range of cytokine concentrations was defined that led to gradual pathway responses in HCC cells (1–5 ng/ml). Repeated stimulations with low (1 ng/ml), medium (2.5 ng/ml) and high (5 ng/ml) TNF amounts demonstrated that JNK signaling was still active at cytokine concentrations, which led to dampened NF-κB signaling illustrating differential pathway responsiveness depending on TNF input dynamics. SiRNA-mediated inhibition of the negative feedback regulator A20 (syn. TNFAIP3) or its overexpression did not significantly affect the NF-κB response. In contrast, A20 silencing increased the JNK response, while its overexpression dampened JNK phosphorylation. In addition, the A20 knockdown sensitized hepatocellular cells to TNF-induced cleavage and activity of the effector caspase-3. In conclusion, a mathematical model-based approach shows that the TNF-induced pathway responses are qualitatively comparable in primary and immortalized mouse hepatocytes. The cytokine amount defines the pathway responsiveness under repeated treatment conditions with NF-κB signaling being dampened ‘earlier’ than JNK. A20 appears to be the molecular switch discriminating between NF-κB and JNK signaling when stimulating with varying physiological cytokine concentrations.

Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro

“…30 Thus, to induce an inflammatory-induced cell death in vitro, TNFα or IL-1β was treated with HUVEC, and then, viability was determined ( Figure S2). TNFα declined cell viability consistent with previous reports, [31][32][33] whereas IL-1β did not affect. Also, their combination exerted effects similar to only TNFα treatment.…”

Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response

“…What we do know from previous research is that low levels of TNFAIP3 are related to germline mutations associated with a plethora of inflammatory diseases (49) such as arthritis, myasthenia gravis (50) autoimmune hepatitis (51) autoimmune lymphoproliferative syndrome (52) and T-cell acute lymphoblastic leukemia (53,54). TNFAIP3 functions an endogenous anti-inflammatory regulator with capacity to down-regulate nuclear factor kappaB signaling, (52) attenuate suppressor of cytokine signaling 3 (55) and JNK phosphorylation (56), with its overexpression triggering tumor apoptosis, and reduction in cytokine release as well as metastasis/migration/ invasion (57)(58)(59)(60).…”

PECAM‐1 modulates liver damage induced by synergistic effects of TNF‐α and irradiation

“…With the enormous progress in this field, it became technically possible to selectively irradiate most types of tumours. 8 It is well known for its role in cell injury probably through the generation of reactive oxygen species (ROS) 7,9,10 or apoptosis. In the liver, a limiting factor for irradiation is radiation-induced liver disease (RILD) also known as radiation hepatitis.…”

“…TNF-α is one of the major AP-cytokines. 8 It is well known for its role in cell injury probably through the generation of reactive oxygen species (ROS) 7,9,10 or apoptosis. 11 In liver, an active involvement of TNF-α in both acute and chronic liver inflammation has extensively been investigated.…”